Angelo M Carella Selected Research

Angelo M Carella Research Topics

Disease

5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 01/2003
5	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 03/2002
3	Multiple Myeloma 09/2019 - 02/2010
3	Hematologic Neoplasms (Hematological Malignancy) 09/2013 - 01/2002
3	Acute Promyelocytic Leukemia 07/2013 - 03/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 02/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 02/2014
2	Infections 01/2017 - 07/2013
2	Lymphoma (Lymphomas) 09/2015 - 01/2008
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2015 - 03/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014 - 06/2003
2	Breast Neoplasms (Breast Cancer) 07/2005 - 01/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Agranulocytosis (Granulocytopenia) 01/2017
1	Arthralgia (Joint Pain) 10/2015
1	Arthritis (Polyarthritis) 10/2015
1	Exanthema (Rash) 10/2015
1	Hairy Cell Leukemia 10/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2015
1	Leukemia 08/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2013
1	Thromboembolism 03/2011
1	Sudden Death 03/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2010
1	Insulin Resistance 07/2010
1	Disseminated Intravascular Coagulation 03/2010
1	Splenic Infarction 03/2010
1	Ischemic Stroke 03/2010
1	Hemorrhage 03/2010
1	Disease Progression 02/2010
1	Neoplasms (Cancer) 01/2004
1	Philadelphia Chromosome 01/2003

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 01/2022 - 02/2012
3	Dexamethasone (Maxidex)FDA LinkGeneric 09/2019 - 06/2002
3	Bortezomib (Velcade)FDA Link 09/2019 - 02/2010
3	fludarabineIBA 01/2017 - 01/2004
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017 - 06/2002
3	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 01/2003
2	Lenalidomide (CC 5013)FDA Link 09/2019 - 01/2017
2	Thalidomide (Thalomid)FDA Link 09/2019 - 03/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 01/2013
2	purineIBA 10/2015 - 01/2004
2	Biological ProductsIBA 02/2014 - 09/2013
2	Phosphotransferases (Kinase)IBA 09/2013 - 02/2010
1	plitidepsin (aplidine)IBA 09/2019
1	Bendamustine Hydrochloride FDA Link 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	nilotinib FDA Link 01/2016
1	fotemustine (Muphoran)IBA 01/2016
1	Pharmaceutical PreparationsIBA 10/2015
1	VemurafenibIBA 10/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2015
1	Busulfan (Busulfex)FDA Link 08/2014
1	YttriumIBA 03/2014
1	ibritumomab tiuxetan (Zevalin)FDA Link 03/2014
1	Monoclonal AntibodiesIBA 03/2014
1	Alemtuzumab (Campath)FDA Link 02/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2013
1	Arsenic Trioxide (Trisenox)FDA Link 07/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	Prednisone (Sone)FDA LinkGeneric 01/2013
1	Vincristine (Oncovin)FDA LinkGeneric 01/2013
1	Methotrexate (Mexate)FDA LinkGeneric 02/2012
1	Enoxaparin (Lovenox)FDA LinkGeneric 03/2011
1	Warfarin (Coumadin)FDA LinkGeneric 03/2011
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2011
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 10/2010
1	CarbohydratesIBA 07/2010
1	Carvedilol (Coreg)FDA LinkGeneric 07/2010
1	Nebivolol FDA Link 07/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	Antihypertensive Agents (Antihypertensives)IBA 07/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2010
1	Dacarbazine (DIC)FDA LinkGeneric 03/2010
1	Etoposide (VP 16)FDA LinkGeneric 06/2002
1	Carmustine (FIVB)FDA Link 06/2002
1	Melphalan (Alkeran)FDA LinkGeneric 06/2002

Therapy/Procedure

9	Therapeutics 09/2019 - 06/2003
7	Stem Cell Transplantation 01/2016 - 03/2002
6	Drug Therapy (Chemotherapy) 01/2016 - 03/2002
5	Homologous Transplantation 05/2010 - 01/2002
4	Transplantation 08/2014 - 06/2002
3	Autologous Transplantation 05/2010 - 01/2002
2	Drug Tapering 01/2017 - 10/2015
1	Induction Chemotherapy 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Aftercare (After-Treatment) 10/2015
1	Dexa-BEAM protocol 06/2002
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2002